HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Henrik Zetterberg Selected Research

Alzheimer Disease (Alzheimer's Disease)

11/2022In-Depth Site-Specific O-Glycosylation Analysis of Glycoproteins and Endogenous Peptides in Cerebrospinal Fluid (CSF) from Healthy Individuals, Mild Cognitive Impairment (MCI), and Alzheimer's Disease (AD) Patients.
11/2022Diagnostic value of serum versus plasma phospho-tau for Alzheimer's disease.
10/2022Ante-mortem plasma phosphorylated tau (181) predicts Alzheimer's disease neuropathology and regional tau at autopsy.
10/2022Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview.
9/2022Biofluid-based biomarkers for Alzheimer's disease-related pathologies: An update and synthesis of the literature.
8/2022Characterization of pre-analytical sample handling effects on a panel of Alzheimer's disease-related blood-based biomarkers: Results from the Standardization of Alzheimer's Blood Biomarkers (SABB) working group.
8/2022CSF biomarkers for dementia.
8/2022Alzheimer's disease biomarkers in Black and non-Hispanic White cohorts: A contextualized review of the evidence.
7/2022Comparative analytical performance of multiple plasma Aβ42 and Aβ40 assays and their ability to predict positron emission tomography amyloid positivity.
7/2022Blood biomarkers for Alzheimer's disease and related disorders.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Henrik Zetterberg Research Topics

Disease

710Alzheimer Disease (Alzheimer's Disease)
11/2022 - 07/2003
243Dementia (Dementias)
11/2022 - 01/2005
214Cognitive Dysfunction
11/2022 - 03/2006
100Neurodegenerative Diseases (Neurodegenerative Disease)
10/2022 - 01/2005
65Inflammation (Inflammations)
11/2022 - 09/2004
65Parkinson Disease (Parkinson's Disease)
05/2022 - 01/2005
55Neuroinflammatory Diseases
11/2022 - 12/2009
49Disease Progression
05/2022 - 12/2011
45Atrophy
02/2022 - 01/2008
42Brain Injuries (Brain Injury)
12/2022 - 12/2009
40Amyloid Plaque
01/2022 - 09/2004
38Frontotemporal Dementia (Semantic Dementia)
11/2022 - 01/2005
35Multiple Sclerosis
10/2022 - 03/2007
28Traumatic Brain Injuries (Traumatic Brain Injury)
03/2022 - 06/2009
25Amyloidosis
06/2022 - 07/2013
21Infections
01/2022 - 06/2010
20COVID-19
11/2022 - 01/2020
19Delirium
06/2022 - 01/2017
19Stroke (Strokes)
01/2022 - 07/2010
18HIV Infections (HIV Infection)
07/2022 - 12/2009
17Normal Pressure Hydrocephalus
02/2022 - 04/2013
15Bipolar Disorder (Manic Depressive Psychosis)
01/2022 - 03/2013
15Parkinsonian Disorders (Parkinsonism)
01/2022 - 03/2009
15Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
10/2021 - 01/2009
14Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome)
01/2022 - 02/2010
14Huntington Disease (Huntington's Disease)
10/2021 - 11/2011
12Down Syndrome (Down's Syndrome)
01/2022 - 01/2014
12Nervous System Diseases (Neurological Disorders)
01/2022 - 10/2008
12Tauopathies
10/2021 - 11/2012
11Heart Arrest (Cardiac Arrest)
06/2022 - 01/2011
11Ischemic Stroke
01/2022 - 01/2014
11Brain Concussion (Cerebral Concussion)
01/2021 - 04/2013
10Encephalitis (Encephalitis, Rasmussen)
11/2022 - 11/2017
10Neurobehavioral Manifestations
06/2022 - 10/2014
10Gliosis
01/2022 - 01/2014
10Lewy Body Disease (Lewy Body Dementia)
01/2022 - 01/2011
9Prion Diseases (Transmissible Spongiform Encephalopathies)
06/2022 - 01/2018
9Brain Diseases (Brain Disorder)
01/2022 - 07/2013
9Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar)
04/2021 - 11/2012
9Cataract (Cataracts)
01/2016 - 11/2005
8Pathologic Processes
11/2022 - 10/2009
8Genetic Risk Score
04/2022 - 01/2017
8Wounds and Injuries (Trauma)
03/2022 - 01/2012
8Emergence Delirium
01/2022 - 01/2019
8Demyelinating Diseases (Demyelinating Disease)
10/2021 - 01/2012
7Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2022 - 10/2008
7Relapsing-Remitting Multiple Sclerosis
01/2022 - 04/2015
7Central Nervous System Infections (Central Nervous System Infection)
12/2021 - 12/2012
7Neoplasms (Cancer)
10/2021 - 03/2006
7Cerebrovascular Disorders (Cerebrovascular Occlusion)
10/2021 - 07/2010
7Chronic Traumatic Encephalopathy
01/2020 - 05/2015
7Craniocerebral Trauma (Head Injury)
01/2020 - 08/2009
6Out-of-Hospital Cardiac Arrest
12/2022 - 02/2014
6Infarction (Infarctions)
11/2022 - 07/2010
6Schizophrenia (Dementia Praecox)
10/2022 - 05/2017
6Major Depressive Disorder (Major Depressive Disorders)
10/2021 - 04/2010
6Hypertension (High Blood Pressure)
01/2021 - 07/2011

Drug/Important Bio-Agent (IBA)

772Biomarkers (Surrogate Marker)IBA
12/2022 - 11/2005
342Amyloid (Amyloid Fibrils)IBA
11/2022 - 09/2004
219Proteins (Proteins, Gene)FDA Link
10/2022 - 09/2004
96Amyloid beta-PeptidesIBA
07/2022 - 05/2004
72Peptides (Polypeptides)IBA
11/2022 - 12/2006
68Apolipoproteins E (ApoE)IBA
04/2022 - 05/2004
57NeurograninIBA
06/2022 - 11/2010
49Glial Fibrillary Acidic ProteinIBA
11/2022 - 04/2010
34Pharmaceutical PreparationsIBA
01/2022 - 01/2010
34ApolipoproteinsIBA
01/2022 - 11/2004
34tau Proteins (tau Protein)IBA
01/2022 - 05/2004
29Biological ProductsIBA
11/2022 - 02/2004
26Amino AcidsFDA Link
04/2022 - 05/2004
24Tumor Necrosis Factor Ligand Superfamily Member 14IBA
01/2022 - 02/2010
19EnzymesIBA
01/2022 - 08/2008
18Protein Isoforms (Isoforms)IBA
01/2022 - 01/2004
15SynucleinsIBA
04/2021 - 01/2014
14CytokinesIBA
01/2022 - 10/2012
14Amyloid Precursor Protein Secretases (beta-Secretase)IBA
12/2021 - 03/2006
12Threonine (L-Threonine)FDA Link
10/2022 - 01/2010
12Glucose (Dextrose)FDA LinkGeneric
01/2021 - 01/2006
11Phosphopyruvate Hydratase (Enolase)IBA
04/2022 - 01/2011
11Serum AlbuminIBA
01/2022 - 04/2010
11Blood Proteins (Serum Proteins)IBA
01/2022 - 10/2007
11Interleukin-8 (Interleukin 8)IBA
11/2021 - 10/2014
10RNA (Ribonucleic Acid)IBA
07/2022 - 01/2017
10NeopterinIBA
01/2022 - 03/2012
9DNA (Deoxyribonucleic Acid)IBA
01/2022 - 11/2005
9Complement System Proteins (Complement)IBA
01/2022 - 07/2012
9LipidsIBA
01/2022 - 02/2012
8Fatty Acid Binding Protein 3IBA
03/2022 - 01/2010
8Chitinase-3-Like Protein 1IBA
11/2021 - 01/2016
7Indicators and Reagents (Reagents)IBA
02/2022 - 11/2013
7Interleukin-6 (Interleukin 6)IBA
01/2022 - 10/2014
7ProteomeIBA
10/2021 - 03/2012
7Neurofilament ProteinsIBA
09/2021 - 07/2013
7ImmunosorbentsIBA
07/2021 - 09/2015
6Glycoproteins (Glycoprotein)IBA
11/2022 - 02/2014
6Monoclonal AntibodiesIBA
01/2022 - 08/2012
6Flavin-Adenine Dinucleotide (FAD)IBA
12/2021 - 01/2018
6AntibodiesIBA
04/2021 - 01/2017

Therapy/Procedure

57Therapeutics
01/2022 - 10/2007
6Highly Active Antiretroviral Therapy (HAART)
01/2021 - 02/2014